Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes
经基因工程改造的成纤维细胞生长因子1变体可将降血糖作用与促细胞分裂活性分离,具有治疗2型糖尿病的潜力。
期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-025-00398-w
Czyrek, Aleksandra A; Krowarsch, Daniel; Sidor, Szymon; Janiszewski, Michal; Drzazga-Wilk, Ewa; Bazydlo-Guzenda, Katarzyna; Buda, Pawel; Pieczykolan, Jerzy; Porebska, Natalia; Minkiewicz, Marta; Krejci, Pavel; Wieczorek, Maciej; Otlewski, Jacek; Zakrzewska, Malgorzata